International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Case Report on Pemphigus Vulgaris

Hephzibah

Abstract: Pemphigus vulgaris (PV) is a chronic inflammatory autoimmune bullous disease. PV almost always affects the mouth and it can be the initial site of presentation in 50% of cases, before skin and other mucosal sites become involved. This is a case of 60-year-old female came with the chief complaints of pain and erosion in the mouth since 1 week. On intra-oral examination solitary, erythematous, pseudomembranous plaque present over the right buccal mucosa. As the patient was diagnosed with pemphigus vulgaris, the goal of therapy was to reduce inflammatory response & autoantibody production. The patient was treated with Methylprednisolone, antifungal & antibiotic along with local anesthetic gel for symptomatic relief. PV is a serious disease, and If left untreated, it could lead to patient's death.

Keywords: pemphigus vulgaris PV, autoimmune, blistering, oral lesions, mucous membrane

How to Cite?: Hephzibah, "Case Report on Pemphigus Vulgaris", Volume 8 Issue 9, September 2019, International Journal of Science and Research (IJSR), Pages: 402-403, https://www.ijsr.net/getabstract.php?paperid=ART2020884, DOI: https://dx.doi.org/10.21275/ART2020884

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.